Jeffrey Kindler and Alfonso "Chito" Zulueta. Both individuals will serve as independent directors, bringing a wealth of experience and expertise to the company.
Jeffrey Kindler boasts an impressive career spanning over four decades, holding leadership positions at renowned companies such as Pfizer, McDonald's Corporation, and General Electric Company. He currently serves as the CEO of Centrexion Therapeutics, a privately held biotechnology company, and holds senior advisory and leadership roles at Blackstone, ARTIS Ventures, and GLG Institute.
Alfonso Zulueta brings extensive experience in the healthcare industry, having served in various leadership roles at Eli Lilly and Company for over three decades. He currently holds the position of Non-Executive Chairman of the board of directors of Interpharma Investments Ltd., the holding company of Zuellig Pharma, a leading healthcare services group in Asia. Additionally, he serves as President & CEO of CZ Ventures and holds board memberships at Glooko, CTS Corporation, and Bridge PayDay Solutions.
Lupin CEO Vinita Gupta expressed her enthusiasm about the appointments, highlighting the invaluable contributions these individuals will make to the company's growth plans. Their expertise in building healthcare institutions, strategic industry perspectives, and deep understanding of the global pharmaceutical landscape are expected to significantly benefit Lupin in the years to come.